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Actin cytoskeleton remodeling is under the regulation of multiple proteins with various activities. Here, we demonstrate that the
γ2isoformofCaseinKinaseI(CKIγ2)ispartofanovelmolecularpathregulatingtheformationofactinstressﬁbers.Weshowthat
overexpression of CKIγ2 in ﬁbroblasts alters cell morphology by impairing actin stress ﬁbers formation. We demonstrate that this
is concomitant with increased phosphorylation of the CDK inhibitor p27Kip and lower levels of activated RhoA, and is dependent
on CKIγ2 catalytic activity. Moreover, we report that roscovitine, a potent inhibitor of cyclin-dependent kinases, including Cdk5,
decreases p27Kip protein levels and restores actin stress ﬁbers formation in CKIγ2 overexpressing cells, suggesting the existence of a
CKIγ2-Cdk5-p27Kip-RhoApathwayinregulatingactinremodeling.Ontheotherhand,wealsoshowthatinamannerindependent
of its catalytic activity, CKIγ2 delays cell cycle progression through G1. Collectively our ﬁndings reveal that CKIγ2 is a novel player
in the control of actin cytoskeleton dynamics and cell proliferation.
1.Introduction
The Rho family of GTPases comprising RhoA, Rac1, and
Cdc42 regulates the organization of the cytoskeleton in
eukaryotic cells [1]. These proteins cycle between an active
GTP-bound and inactive GDP-bound state through the
action of GTPase exchange factors (GEFs) and GTPase acti-
vating proteins (GAPs) [2]. Once activated, RhoA regulates
a c t i ns t r e s sﬁ b e r sf o r m a t i o n[ 3], while Rac1 triggers the
assembly of actin in lamellipodia and membrane ruﬄes [4]
and Cdc42 induces ﬁlopodial extensions [5] at the leading
edge of the cell. Over the years, Rho GTPases were found to
be crucial regulators of actin remodeling involved in a great
deal of normal cellular functions, including cell migration
and adhesion, cell cycle progression, and membrane traﬃck-
ing [6]. In addition, Rho GTPases contribute to pathological
conditions, particularly to cancer initiation and metastasis
by controlling cell proliferation, migration, and adhesion
during oncogenic transformation [7–9].
Accumulating evidence suggests that Rho GTPases are
regulated at least in part by the cyclin-dependent kinase
inhibitors (CDKIs) p21Waf/Cip,p 2 7 Kip1,a n dp 5 7 Kip2 through
diﬀerent mechanisms. As example, p27Kip1, which depends
on its abundance and nuclear localization to inhibit the
cyclin-dependent kinases (CDKs), inhibits RhoA activation
in a cell-cycle independent manner, thereby modulates actin
dynamics [10]. In fact, p27Kip1 phosphorylation at Ser10
increases its stability and cytoplasmic localization [11, 12],
where it binds to and inhibits RhoA by interfering with
the interaction between RhoA and its activating GEFs
[10]. Among protein kinases that regulate p27Kip1, cyclin-
dependent kinase 5 (Cdk5), also known as a regulator
of actin dynamics, was found to stabilize p27Kip1 through
phosphorylation of p27Kip1 at Ser10 in cortical neurons
[13]. However, whether Cdk5 possesses similar activity in
nonneuronal cells remains to be determined.
Casein kinase I (CKI) encompass a large family of
Ser/Thr protein kinases encoded by separate genes and
several splice variants. The 7 mammalian CKI isoforms
identiﬁed so far, namely, α, β, γ1–3, δ,a n dε, share high
degree of identity within their kinase domain, but diﬀer
signiﬁcantly in the length and amino acid composition of
their N- and C-termini [14]. Overall, CKIs are conserved
throughout evolution and involved in diverse cellular func-
tions [15]. CKIα, δ,a n dε involved in vesicular traﬃcking
[16–18] are also implicated in canonical Wnt signaling, but2 International Journal of Cell Biology
with distinct role [19]. CKIδ transduces speciﬁc centrosome
functions [20], but, like CKIε, it also contributes to the
regulation of the circadian rhythm [21, 22], apoptosis
[23], and neuronal neurite outgrowth [24]. Interestingly,
among the CKI family, the closely related CKIγ proteins
(CKIγ1, 2, and 3) are unique in carrying C-terminal lipid
modiﬁcation motif that is believed to anchor them at
the plasma membrane [25, 26]. In agreement with CKIγ
plasma membrane localization, expression of the Xenopus
tropicalis CKIγ in vertebrates and Drosophila cells has been
implicated in transducing early signaling events of LRP6, a
cell surface membrane receptor involved in Wnt signaling
[25]. However, very little is known regarding the function
of individual mammalian CKIγ isoforms. Previously, we
reported that the Src homology (SH) domain-containing
adaptor protein Nck directly interacts with CKIγ2 through
two of its SH3 domains [27], while we determined that
a proline rich motif (P343DVPSQPR352) unique to the C-
t e r m i n a ln o n c a t a l y t i ct a i lo fC K I γ2 is mediating binding of
Nck (unpublished data). Given that Nck transduces signals
frommembranereceptorproteintyrosinekinasestoeﬀectors
regulating crucial biological cellular responses such as actin
cytoskeletal reorganization and cell proliferation, we further
investigated CKIγ2 function in mammalian cells.
In this study, we provide evidence that the kinase activity
is required for CKIγ2t or e g u l a t ea ct i nc yt o s k e l e t o nr e m o d e l -
ing through its ability to downregulate RhoA proteins and
signaling via the activation of the Cdk5-p27Kip1 pathway.
In addition, our ﬁndings also reveal that in a manner
independent of its catalytic activity, CKIγ2 also regulates cell
proliferation.
2.MaterialsandMethods
2.1. CKIγ Constructs. The mouse CKIγ1, 2, and 3 full
length cDNAs were subcloned downstream of a Kozak
sequence and in frame with a HA epitope sequence into
the mammalian expression vector pZeoSV2 (Invitrogen). A
kinase deﬁcient (KD) CKIγ2 full length cDNA was generated
by introducing a point mutation (K75R) in the ATP-binding
site. A cDNA (1–1020nts) encompassing the kinase domain,
but lacking the C-terminal extension of CKIγ2( Δ C-term),
was generated by PCR using appropriate speciﬁc primers
and further subcloned into pZeoSV2 as reported above. All
constructs were fully sequenced to conﬁrm their identity and
to ensure that no unwanted mutation had been introduced
during their creation.
2.2.StableCellLinesofFibroblastOverexpressingCKIγ2. Rat-
2 ﬁbroblasts were cultured in DMEM (Dulbecco’s modiﬁed
Eagle’s medium; Life Technologies, Inc) supplemented with
2mM L-glutamine, 45mM sodium bicarbonate, and 10%
FBS at 37◦C, in a humidiﬁed atmosphere of 95% air and
5% CO2. Using calcium phosphate precipitation, ﬁbroblasts
were transfected with indicated expression plasmids. Upon
selectioninmediumcontaininghighconcentrationofzeocin
(500μg/mL) or G418 (400μg/mL) for cells transfected,
respectively, with pZeoSV2 or pcDNA 3.1, individual clones
were isolated, grown, and analyzed for expected proteins
expression. Positive clones were propagated under the same
conditions, except that 50μg/mL zeocin or 40μg/mL G418
was added to the culture medium. For ﬁbroblasts transfected
with the empty pZeoSV2 plasmid, instead of individual
clones following zeocin selection procedure, a pool of
resistant cells was propagated and used as control.
2.3. Cell Culture and Transient Transfection. Rat-2 and
HaCaT cellswere grown in DMEM and HepG2 cellsin Mini-
mumEssentialMediumAlphaMedium(MEM)(Invitrogen)
supplemented with antibiotic/antimycotic (Invitrogen) and
10% heat-inactivated fetal bovine serum (FBS) (Invitrogen)
at 37◦Ci n5 %C O 2/95% O2.F o rC K I γ1, 2, and 3 transient
expression into Rat-2 cells, cells plated at 80% conﬂuency
in 60mm dishes were transiently transfected with indi-
cated expression plasmids using Lipofectamine-Plus reagent
(Invitrogen) according to the manufacturer’s instructions.
2.4. SiRNA Transfection. Human CK1γ2 siRNAs targeting
two independent coding regions (R1 and R2) were
purchased from Integrated DNA technologies (IDT)
R1(5 -GCACCUGGAGUACCGGUUC-3 ) and R2(5 -
GCGCUACAUGAGCAUCAAC-3 ). Scrambled siRNA
obtained also from IDT was used as control. HepG2 and
HaCaT cells were transiently transfected with indicated
siRNA using Lipofectamine RNAiMAX reagent (Invitrogen)
according to the manufacturer’s instructions. Brieﬂy,
300μmol of siRNA was added to 500μLo fO p t i - M E MI
Medium without serum (Invitrogen) in 6-well plates and
mixed gently. 5μL of Lipofectamine RNAiMAX reagent
was added to each well containing diluted siRNAs, mixed
gently, and incubated at room temperature for 20min. In
the meantime, cells were harvested, counted, and diluted at
200 000 cells/mL in MEM media without antibiotics. Then,
2.5mL of cells suspension (i.e., 500 000 cells/well) were
added to each well and mixed gently, making the ﬁnal siRNA
concentration at 100nM. The cells were further incubated at
37◦C for 48–72 hours.
2.5. Antibodies, Immunoprecipitation, and Western Blots. To
immunoprecipitate HA-tagged CKIγ2, we used the commer-
cial HA F-7 antibody (Santa Cruz). For western blot analysis,
the following antibodies were used: HA Y-11 (Santa Cruz);
p53 FL-393 (Santa Cruz), Nck 1794 (in house [27]), p21Cip1
C-10 (Santa Cruz); p27Waf1 C-19 (Santa Cruz) and RhoA F-
1 (Santa Cruz). To detect CKIγ2, we generated a rabbit poly-
clonalantibodyusingaKHL-coupledCKIγ2peptideenc om-
passing aa 331–354 as antigen. In general, cells were lysed
in lysis buﬀer (50mM Hepes, pH 7.5, 150mM NaCl, 10%
Glycerol, 1% Triton X-100, 1.5mM MgCl2,1 m ME G T A ,
10mM sodium pyrophosphate, 10mM sodium ﬂuoride)
supplemented with 2μg/mL leupeptin and aprotinin as well
as with 1mM phenyl-methylsulfonyl ﬂuoride (PMSF) and
200μMactivatedsodiumorthovanadate.Clariﬁedcelllysates
were normalized to equal protein concentrations with the
lysis buﬀer and protein immunoprecipitations performedInternational Journal of Cell Biology 3
using appropriate antibodies. Immune complexes were sub-
sequently collected with Protein A-Agarose (SantaCruz),
and, after several washes with the lysis buﬀer, proteins were
eluted in Laemmli buﬀer [28], boiled, and subjected to SDS-
PAGE.WesternBlotswereperformedaspreviouslydescribed
[29] using chemiluminescence (ECL Plus, GE Healthcare,
UK). When mentioned, equal amounts of total cell proteins
were subjected to SDS-PAGE and subjected to Western Blot
analysis following the same protocol.
2.6. In Vitro Kinase Assays. Immunoprecipitated proteins
immobilized on Protein A beads or recombinant GST fusion
proteins were washed ﬁve times with lysis buﬀer and three
times with the kinase buﬀer before being divided in two
aliquots, which were, respectively, subjected to in vitro kinase
assay and immunoblot. For CKI activity, the kinase buﬀer
was composed of 20mM Hepes, pH 7.5, 1mM dithiothreitol
(DTT), 5mM MgCl2,1 0m Mβ-glycerophosphate, and 5μg
of α-casein as exogenous substrate. For all assays, following a
preincubation at 30◦C for 5min, the reactions were initiated
by adding [γ-32P]-ATP (50μM, 5–10μCi) (DuPont, NEN)
and further incubated for 20min at 30◦C. The reactions
were stopped by adding Laemmli buﬀer, boiled, subjected to
SDS-PAGE and then to autoradiography. Phosphorylation of
exogenous substrates was analyzed by densitometry (Imag-
ingDensitometer,ModelGS-800,BioRad).Toassesswhether
CKIγ2 phosphorylates RhoA in vitro, 200ng of puriﬁed
recombinant GSTCKIγ2 full length (FL) or truncated of its
C-terminal (Δ C-term) were incubated with 1μgo fp u r i ﬁ e d
recombinant RhoA as reported above.
2.7. Cell Proliferation. Proliferation of stable ﬁbroblast cell
lines was evaluated by counting the number of cells, diﬀerent
times after plating. Cells were seeded at 5 × 103 cells/60mm
plate, in triplicate for each time points and cell lines. On
days 3, 5, and 7 after plating, the cells were trypsinized and
counted using a hemocytometer.
2.8. 3H-Thymidine Incorporation. Cells were plated at
2 × 104 cells/well in 24 wells plates and grown for 24 hours
in DMEM containing 10% FBS. The next day, the cells were
starved for 36 hours in DMEM supplemented with 0.1%
BSA. At the end of the starvation period, the medium was
replaced by fresh starving medium with or without FBS at
2.5% or PDGF at 25ng/mL and the cells incubated for an
additional 24 hours. During the last 8 hours of stimulation,
0.5μCi of 3H-Thymidine was added. Thymidine incorpo-
ration was stopped by replacing the medium by cold TCA
(10%) and further incubation at 4◦C. Precipitated material
was then solubilized in 0.3N NaOH and incorporated 3H-
Thymidine counted by liquid scintillation using a LKB 1219
Rack Beta Liquid scintillation Counter.
2.9. DNA Laddering. Following washes with PBS, serum
growing cells in culture dishes were directly lyzed in 0.5mL
of DNAzol genomic isolation reagent (Molecular Research
Center, Inc., Cincinnati, OH). The resulting lysates were
subjected to repeated pipetting and DNA precipitation
performed by adding 0.25mL of 100% ethanol. Samples
were mixed by inverting the tubes 5–8 times and kept at
room temperature for 3min. Precipitated DNA was then
spooled using a pipette tip, washed twice in 70% ethanol,
and dissolved in water. Samples of total DNA were separated
on 1.8% agarose gel and stained with ethidium bromide.
As positive control, primary rat thymocytes maintained in
culture in DMEM supplemented with 10% FBS were treated
with10μg/mL of anisomycin for 24 hours. Thymocytes were
collected by centrifugation, washed with PBS and genomic
DNA prepared as described above.
2.10.CellCycleAnalysis. Forﬂowcytometryanalysis(FACS),
1 × 106 of serum growing cells were collected, ﬁxed in 70%
ethanol following incubation for 15min on ice and storage
for at least 1 hour at −20◦C. Fixed cells were washed in cold
PBS, and stained with propidium iodide (PI, Sigma) using a
solution containing 50μg/mL of PI and 10μg/mL of RNAse
in PBS at 37◦C for 30min. Quantiﬁcation of cell populations
in diﬀerent phases of the cell cycle was determined using the
Cell Quest software (Becton Dickinson, CA).
2.11. Cell Morphology and Actin Staining. Cells plated on
coverslips were rinsed with PBS before being ﬁxed for 10min
at room temperature in 4% formaldehyde/PBS. Following
ﬁxation, coverslips were rinsed with PBS and the cells
permeabilized in 0.2% Triton X-100/PBS for 5min at room
temperature. For ﬁlamentous actin staining, cells were incu-
bated with rhodamine-conjugated phalloidin (0.1μg/mL;
Sigma, Oakville, ON. Canada) or phalloidin-coupled to
Alexa Fluor 488Fluor for 30–60min at room temperature.
For HA-staining, we used the commercially available anti-
HA 12CA5 (Roche Apllied Science). Coverslips were washed
with PBS and water prior to being mounted with Mowiol
and examined on a Zeiss Axiovert 200 microscope at 40X
or 63X using Zeiss oil immersion. Fluorescence images were
subsequently captured using a digital camera (DVC) and
analyzed with Northern Eclipse software (Empix Imaging
Inc.). Images were transferred to Adobe Photoshop and
assembled with PowerPoint.
2.12. Rho Activation Assays. Essentially, levels of activated
RhoA (RhoA-GTP) were assessed using the Rho activation
kit purchased from Millipore (cat. no. 17–294). Brieﬂy,
serumgrowingﬁbroblasts(R2ZeoandZ23),about70%con-
ﬂuent, were transiently transfected with a vector-encoding
Myc-tagged RhoA (100ng) using Lipofectamine Plus (Invit-
rogen). Cells lysates prepared 16 hours after transfection
were mixed with 60μg of recombinant GST-Rhotekin Rho
binding domain previously isolated on beads. Following
45min at 4◦C, beads were washed three times, boiled in
Laemmli sample buﬀer, and bound proteins separated on a
12% SDS-polyacrylamide gel. Levels of Myc-tagged RhoA
proteins bound to the fusion protein or present in the
w h o l ec e l ll y s a t e sw e r ee v a l u a t e db yw e s t e r nb l o t t i n gw i t h
a rabbit polyclonal anti-Rho antibody (RhoA, B, and C)
provided with the kit and ECL Plus detection as reported
above.4 International Journal of Cell Biology
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Figure 1:CKIγ2overexpressioninﬁbroblastsalterscellmorphologyandactinstressﬁbersformation.(a)Isolatedclonesofﬁbroblastsstably
transfectedwithaplasmidencodingHA-tagged-CKIγ2(A20,Z6,andZ23)orpoolofstablecellstransfectedwithanemptyplasmid(R2Zeo)
were analyzed for HA-CKIγ2 expression by Western Blot (WB) on HA immunoprecipitates (IP). (b) CKIγ2 activity determined on HA
immunoprecipitates in in vitro kinase assays using phosphorylation of exogenous α-casein. (c) Indicated serum growing cells were analyzed
for cell morphology by phase contrast microscopy (40X) and (d) actin organization using rhodamine-conjugated phalloidin staining (63X).
R2Zeo: control; A20, Z6, and Z23: clones overexpressing increasing levels of CKIγ2.
2.13. Cells Stimulation. Cells (6 × 104) were plated on
coverslips 24 hours prior to be serum starved for 24 hours in
DMEM/0.1% BSA and subsequently treated with 50ng/mL
of lysophosphatidic acid (LPA, Sigma) for 30min at 37◦Co r
overnight. For roscovitine experiments, we treated the cells
overnightwith25μMroscovitine(Sigma).Controlcellswere
exposed to equivalent volume of vehicle. Cells were then
washed, stained for ﬁlamentous actin using phalloidin and
mounted for immunoﬂuorescence microscopy or processed
for western blot analysis as previously described.
3. Results
3.1. CKIγ2 Overexpression in Fibroblasts Alters Cell Mor-
phology and Inhibits Actin Stress Fibers Formation in a
Kinase-Dependent Manner. To investigate the role of CKIγ2
in mammalian cells, we generated ﬁbroblasts that stably
overexpress CKIγ2 by transfecting a plasmid encoding
N-terminal HA-tagged wild-type CKIγ2[ 29]. Fibroblasts
transfected with an empty plasmid are considered as control.
We selected a pool of empty plasmid transfected cells
(R2Zeo) as control and three independent clones expressing
diﬀerent levels of the 50–55kda HACKIγ2p r o t e i n( A 2 0<
Z6 < Z23) to further study (Figure 1(a)). We demonstrated
the activity of HA-CKIγ2 by performing in vitro kinase
assays on HA immunoprecipitates (IP) using α-casein as
exogenous substrate (Figure 1(b)). Visual examination of
these cells foremost revealed that ﬁbroblasts overexpressing
higher levels of CKIγ2 (Z6 and Z23) presented marked
change of morphology when compared with ﬁbroblasts
overexpressing lower levels of CKIγ2 (A20) or mock-
transfected ﬁbroblasts (R2Zeo) (Figure 1(c)). We observedInternational Journal of Cell Biology 5
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Figure 2: CKIγ2 overexpression in ﬁbroblasts impairs cell motility.
Migration of serum starved control (R2Zeo) and HA-CKIγ2
overexpressing ﬁbroblasts (Z23) were evaluated in wound healing
assays. Pictures (10X) from the same area were taken at time 0 and
16 hours after the wound.
that cells harboring higher levels of CKIγ2 (Z6 and Z23) lost
their ﬁbroblastic elongated shape to acquire a more rounded
morphology. Actin staining with phalloidin demonstrated
that the rounded shrunken morphology of these cells (Z6
and Z23) is associated with a drastic decrease in actin stress
ﬁbers (Figure 1(d)).
To assess whether loss of actin stress ﬁbers in ﬁbroblasts
overexpressing CKIγ2a ﬀects cell motility, we compared
the migratory activity of ﬁbroblasts overexpressing CKIγ2
(Z23) with control ﬁbroblasts (R2Zeo) using in vitro wound
healingassays.Toensurethatcellsinthewoundedarearesult
from cell motility, rather than proliferation, ﬁbroblasts were
deprived from serum for 24 hours prior to performing the
wound. As shown in Figure 2, ﬁbroblasts that overexpress
CKIγ2 did not migrate and ﬁll the wounded area at a rate
comparable to control ﬁbroblasts. Altogether, these obser-
vations indicate that overexpression of CKIγ2 in ﬁbroblasts
induces dissolution of actin stress ﬁbers and impairs cell
motility in vitro.
Wenextinvestigatewhetherthekinaseactivityisrequired
for CKIγ2 to inhibit the formation of actin stress ﬁbers.
For this, we generated two independent clones of ﬁbroblasts
stably overexpressing a kinase deﬁcient form of CKIγ2( K D 1 ,
KD30) at levels almost comparable to wild-type CKIγ2l e v e l s
detected in the Z23 cell line (Figure 3(a), upper panel). As
expected, CKIγ2K D( K 7 5 R )i sd e v o i do fc a t a l y t i ca c t i v i t y
as shown by the absence of α-casein phosphorylation in
HA-immunoprecipitated CKIγ2K Di nin vitro kinase assays
(Figure 3(a), lower panel). However, we observed similar
to control cells (R2Zeo) morphology and levels of actin
stress ﬁbers organization in ﬁbroblasts overexpressing kinase
deﬁcient CKIγ2( K D )( Figure 3(b)). This demonstrates that
the kinase activity of CKIγ2 is required for the inhibition of
actin stress ﬁbers formation.
To demonstrate that the regulation of actin stress ﬁber
formation by CKIγ2 occurs not only in overexpressing
conditions, we assessed actin stress ﬁbers in HaCaT human
keratinocytes transiently transfected with two siRNAs (R1,
R2) derived from short hairpin-type RNA constructs tar-
geting independent coding regions of hCKIγ2 that have
been reported to eﬀectively downregulate CKIγ2 in these
cells [30]. As shown in Figure 4, HaCaT cells treated with
CKIγ2 siRNAs substantially present increased formation of
stress ﬁbers, supporting a physiological role for CKIγ2i n
regulating actin cytoskeleton reorganization.
3.2. CKIγ2 Overexpression in Fibroblasts Decreases RhoA
Protein and RhoA-GTP Levels. Formation of actin stress
ﬁbers is under the control of the small GTPases Rho [3];
therefore, we ﬁrst compared the levels of RhoA protein
in ﬁbroblasts overexpressing CKIγ2 with control ﬁbroblasts
(Figure 5(a)). Interestingly, we found that overexpression
of CKIγ2 results in decreased levels of the RhoA proteins,
suggesting that dissolution of actin stress ﬁbers in CKIγ2
overexpressingﬁbroblastsmightbeduetolowlevelsofRhoA
proteins that yield to noneﬃcient RhoA signaling activity.
To further investigate this point, we expressed Myc-RhoA in
ﬁbroblasts overexpressing or not CKIγ2 and determined the
levels of active Myc-RhoA-GTP by measuring the amount
of Myc-RhoA proteins bound by a GST fusion protein
encoding the Rho-binding domain of Rhotekin. Consistent
with decreased actin stress ﬁbers and lower RhoA protein
levels in ﬁbroblasts overexpressing CKIγ2, we found lower
levels of activated RhoA (Myc-RhoA-GTP) as well as total
Myc-RhoA in cells overexpressing higher levels of CKIγ2
(Figure 5(b)). To further support that increased expression
of CKIγ2 downregulates RhoA protein levels, we transiently
transfected Rat-2 ﬁbroblast with increasing amounts of
plasmid encoding HA-CKIγ2 and assessed expression levels
of HA-CKIγ2 and RhoA in total cell lysates by western
blotting. In agreement with decreased levels of RhoA protein
in ﬁbroblasts overexpressing high levels of CKIγ2 (Z23),
transient expression of high levels of CKIγ2 leads to lower
levels of RhoA protein (Figure 5(c)). Altogether, these data
suggest that CKIγ2 contributes to lowering the expression or
enhancing the degradation of RhoA and this could result in
attenuated RhoA signaling.
To determine whether ﬁbroblasts overexpressing CKIγ2
can still be challenged by external stimuli to build up actin6 International Journal of Cell Biology
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Figure 3: The catalytic activity of CKIγ2 is required to induce change in cell morphology and actin stress ﬁbers in ﬁbroblasts. (a) Isolated
clones of ﬁbroblasts stably transfected with a plasmid encoding HA-tagged wild-type CKIγ2 (Z23), HA-tagged kinase deﬁcient CKIγ2 (KD1
and KD30), or pool of stable ﬁbroblasts transfected with an empty plasmid (R2Zeo) were analyzed for HA-CKIγ2 expression by HA Western
Blot (WB) on HA immunoprecipitates (IP) and CKIγ2 activity as determined on HA immunoprecipitates from equal amounts of protein
normalizedcelllysatesandinvitrokinaseassaysusingα-caseinassubstrate.KD1andKD30:clonesthatoverexpresskinasedeﬁcientCKIγ2at
thesamelevelsascellsstablyoverexpressingwild-typeCKIγ2(Z23).(b)Morphologyofserumgrowingcellswasvisualizedbyphasecontrast
microscopy (40X) (upper panels) and actin organization by actin staining with rhodamine-conjugated phalloidin (63X) (lower panels).
siRNA control siRNA CKIγ2 R2 siRNA CKIγ2 R1
Figure 4: Increased actin stress ﬁbers in HaCaT cells transiently transfected with hCKIγ2 siRNAs. HaCaT cells transiently transfected with
siRNA control or siRNAs targeting two independent coding regions of hCKIγ2 (R1, R2) were subjected to actin staining using phalloidin-
coupled to AlexaFluor 488. Pictures were taken at 63X.International Journal of Cell Biology 7
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Figure 5: Overexpression of CKIγ2 in ﬁbroblasts reduces the levels of RhoA protein and RhoA activation. (a) Fibroblasts stably
overexpressing CKIγ2 (Z23) and control ﬁbroblasts (R2Zeo) were analyzed for RhoA protein expression levels by Western Blot using
equivalent amount of total cell lysate proteins. (b) Levels of activated Myc-RhoA (Myc-RhoA-GTP) were assessed following transient
expression of MycRhoA in serum growing ﬁbroblasts control (R2Zeo) or overexpressing CKIγ2 (Z23) using pull down of equivalent amount
of total cell lysate proteins with a GST fusion protein encoding the Rho-binding domain of Rhotekin. (c) Total cell lysates from ﬁbroblasts
transiently transfected with increasing amount of plasmid encoding HA-CKIγ2 were subjected to Western Blot analysis with indicated
antibodies.
stress ﬁbers, we treated these cells with the serum-borne
phospholipid lysophosphatidic acid (LPA), a G-protein-
coupled receptor agonist which regulates the assembly of
actin stress ﬁbers through the activation of RhoA [31]. Actin
staining of ﬁbroblasts expressing high levels of HA-CKIγ2
in response to LPA stimulation at 50ng/mL for 10–30min
revealed that, in all conditions, LPA treatment results in
formation of actin stress ﬁbers (Figure 6(a)). Finally, actin
stress ﬁbers could be rescued by expressing a constitutively
active RhoA (RhoAL63) in ﬁbroblasts overexpressing CKIγ2.
Altogether, these data suggest that signaling downstream of
RhoA is intact in ﬁbroblasts overexpressing CKIγ2 and it
also could be eﬃciently challenged to lead to the formation
of actin stress ﬁbers (Figure 6(b)). Overall, our observations
provide strong evidence supporting that CKIγ2-mediated
inhibition of RhoA-dependent formation of actin stress
ﬁbers is reversible and could result from impaired expression
and activation of the GTPases Rho.
3.3. RhoA Is Not Phosphorylated by CKIγ2I nV i t r o . As serine
phosphorylation of Rho proteins negatively regulates their
activity, we determined whether CKIγ2 could directly phos-
phorylate RhoA in vitro. For this, we incubated GST fusion
protein encoding CKIγ2 full length (FL) or truncated with
its noncatalytic C-terminal domain deleted (Δ C-term), with
recombinant RhoA in presence of [γ-32P] ATP and assessed
32P labeling of RhoA upon SDS-PAGE and autoradiography.
AsshowninFigure 7,CKIγ2fulllengthandCKIγ2deletedof
itsC-terminaldomainautophosphorylateinvitro,suggesting
that these are active protein kinases. In contrast, RhoA
was not phosphorylated by either GST-CKIγ2 constructs,
suggesting that in vivo CKγ2 does not induce actin stress
ﬁbersdisassemblybydirectlyphosphorylatingandinhibiting
RhoA.
3.4. CKIγ2 Overexpression in Fibroblasts Inhibits Cell Prolif-
eration and Delays Cell Cycle Progression in G1. In addition
to the eﬀect of overexpressing CKIγ2o nc e l lm o r p h o l o g y ,
we found that ﬁbroblasts overexpressing CKIγ2p r o l i f e r a t e
at a signiﬁcant slower rate compared with control ﬁbroblasts
(Figure 8(a)). In addition, decreased proliferation appears to
correlate with the extent of CKIγ2 overexpression. Dimin-
ished proliferation in cells overexpressing CKIγ2 was further
conﬁrmed by decreased incorporation of 3H-thymidine into
DNA in response to PDGF, a potent mitogenic factor for
ﬁbroblast [32], or serum over a 24-hour period of stimula-
tion (Figure 8(b)). For an unknown reason, incorporation
of 3H-thymidine in response to PDGF or serum stimulation8 International Journal of Cell Biology
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Figure 6: LPA stimulation and activated RhoA rescue actin stress ﬁbers formation in ﬁbroblasts overexpressing CKIγ2. (a) Actin staining
following LPA stimulation (50ng/mL, 10–30 minutes, and 37◦C) in serum-starved ﬁbroblasts control (R2Zeo) or stably overexpressing
CKIγ2 (Z6 and Z23). Pictures were taken at 63X. (b) Myc, Actin, and DAPI staining of CKIγ2 overexpressing ﬁbroblasts (Z23) transiently
transfected with a cDNA encoding a constitutively activate form of RhoA (Myc-RhoA L63). Pictures were taken at 40X.
in ﬁbroblasts overexpressing higher levels of CKIγ2( Z 6
and Z23) is often decreased compared with their respective
unstimulated basal levels (Z6: Bas 5,300 ± 196, PDGF
3,205 ± 103, FBS 4,098 ± 110; Z23: Bas 8,071 ± 192, PDGF
3,672 ± 212, FBS 6,853 ± 327cpm). Therefore, to exclude
cell death as an important factor contributing to decreased
proliferation, all cell lines were subjected to DNA laddering
assay (Figure 8(c)) and DAPI staining (data not shown).
As a positive control for DNA laddering, we used primary
culturedratthymocytestreatedfor24hourswithanisomycin
(10ug/mL). Using both approaches, we established that
apoptosis is not responsible for the apparent decrease in
proliferation of cells overexpressing CKIγ2. In agreement,
signiﬁcant increase in doubling time calculated from growth
curvesforallaforementionedcelllinesoverexpressingCKIγ2
compared with control ﬁbroblasts suggests that overexpres-
sion of CKIγ2 increases cell cycle duration (Table 1). To test
this hypothesis, we performed FACS analysis to determine
the distribution of actively serum growing asynchronized
cells stably overexpressing CKIγ2 throughout the diﬀerent
phases of the cell cycle. As reported in Table 2, 50% of
controlﬁbroblastsmock-transfectedweredetectedinG1andInternational Journal of Cell Biology 9
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Figure 7: RhoA is not phosphorylated by CKIγ2 in vitro.R e c o m -
binant GST-CKIγ2 full length (FL) or C-terminal truncated (Δ C-
term) (200ng) puriﬁed on beads was incubated with recombinant
RhoA (1μg) in in vitro kinase assays. Incorporation of 32Pw a s
revealed by autoradiography of the kinase reactions resolved
on SDS-PAGE. Respective proteins are indicated, and equivalent
amount of RhoA used in the assays was revealed by Coomassie blue
staining.
Table 1: Calculated doubling time from cell proliferation assays.
Clones Doubling time (hours)
Control R2Zeo 17.3 (0.3)
HA-CKI-γ2-Wild Type
A20 18.8 (0.4)∗
Z6 23.1 (0.5)∗
Z23 27.1 (0.3)∗
Values are the means (SEM) of assays.∗P at least ≤ 0.005 compared to
control.
the remaining cell population was evenly distributed into
S and G2 phases (approximately 23%, resp.). In contrast,
ﬁbroblasts overexpressing CKIγ2 presented a signiﬁcant
larger population of cells in G1 (63–70%) and a reduced
percentageofcellsinSandG2phases(12–17%).Collectively,
these results indicate that CKIγ2 inhibits cell proliferation by
modulating cell cycle progression through G1.
3.5. Overexpression of CKIγ2 in Fibroblasts Increases Expres-
sion of the CDK Inhibitors p21Cip1 and p27Kip1 and the Tumor
Suppressor p53. Consistent with a larger population of cells
in G1 and reduced thymidine incorporation into DNA
during the S phase of the cell cycle, earlier G1 phase cell
cycle events could account for the antiproliferative eﬀect of
CKIγ2. To address this, we then compared the expression
of the CDKIs p21Cip1 and p27Kip1 and the tumor suppres-
sor p53 in ﬁbroblasts overexpressing CKIγ2w i t hc o n t r o l
ﬁbroblasts. Our investigation revealed that inhibition of cell
Table 2: Cell distribution in diﬀerent phases of cell cycle deter-
mined by FACS analysis.
Clones % ﬂuorescence at cell cycle phase
G 1SG 2
Control R2Zeo 50.3 (0.2) 23.6 (0.2) 23.8 (0.1)
HA-CKI-γ2-Wild Type
Z6 67.6 (0.4)∗ 12.3 (0.4)∗ 15.3 (0.6)∗
Z23 70.2 (0.3)∗ 17.0 (0.2)∗ 12.1 (0.4)∗
Cells were ﬁxed with 70% ethanol, stained with propidium iodide, and
subjected to ﬂow cytometry analysis. Values are mean (SEM) of 4 assays. ∗P
at least ≤ 0.00001 compared to control.
proliferation and delay in cell cycle progression in ﬁbroblasts
overexpressing CKIγ2 correlate with increased expression
of p21Cip1,p 2 7 Kip1, and p53 (Figure 9(a)). Surprisingly, the
eﬀects of CKIγ2 on cell cycle regulators are independent of
its catalytic activity as shown in ﬁbroblasts overexpressing
CKIγ2 kinase dead (KD1 and 30) (Figure 3) that still shows
increased expression of p21Cip1,p 2 7 Kip1 and p53 proteins.
This is in contrast with the eﬀects of CKIγ2o na c t i n
reorganization that require the catalytic activity of CKIγ2
(Figure 3). Interestingly, increased expression of p21Cip1 and
p27Kip1 appear, to be CKIγ2 dosage independent compared
to increased expression of p53 which correlates with the
levels of CKIγ2 overexpressed (Figures 9(a) and 9(b)).
Overall, these ﬁndings demonstrate that CKIγ2i m p a i r sc e l l
proliferationbydelayingcellsintheG1phaseofthecellcycle.
Likewise, the fact that ﬁbroblasts overexpressing CKIγ2a r e
still evenly distributed in S and G2 phases of the cell cycle
suggeststhatthesestepsproceednormallyandthattheeﬀects
of CKIγ2 on cell proliferation are restricted to the G1 phase
of the cell cycle.
To further demonstrate a role for CKIγ2 on expression
levels of CDK inhibitors, we compared p27Kip1 protein
expression levels between HepG2 cells transfected with
CKIγ2 speciﬁc siRNAs and scramble siRNA (Figure 10).
Using this approach, we found that eﬃcient downregulation
of CKIγ2 in HepG2 cells leads to decreased expression of
p27Kip1 proteins.
CKIγ2 is closely related to CKIγ1 and 3, and, like CKI γ2,
CKIγ1and3arebelievedtoalsobemembraneassociateddue
to a putative palmitoylation site present in their C-terminus
[25]. In attempt to determine to what extend the eﬀects of
CKIγ2o np 2 7 Kip1 and actin stress ﬁber are isoform speciﬁc,
wefailedtoestablishstableﬁbroblastcelllinesoverexpressing
CKIγ1 or 3, most likely due to toxicity as reported by others
[33]. This was also the case for transient overexpression
of CKIγ1 in ﬁbroblasts, while transient overexpression of
CKIγ2orγ3waspossible.Therefore,wecarriedouttransient
transfection of ﬁbroblasts with an empty plasmid as control,
or plasmid encoding either HA-tagged CKIγ2o rγ3a n d
monitored p27Kip1 levels and actin organization using these
cells(Figure 11).Asreportedabove,expressionofHA-tagged
CKIγ2o rγ3 was detected using total cell lysates in Western
Blot with anti-HA antibody (Figure 11(a)). Interestingly, as
observed in stable cell lines overexpressing CKIγ2, transient10 International Journal of Cell Biology
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Figure 8: CKIγ2 overexpression in ﬁbroblasts reduces cell proliferation. (a) Cell proliferation was examined by seeding each cell line in
triplicate at 3 × 105 cells/60mm plate on day 0. On days 3, 5, and 7, cells were trypsinized and counted. Results are expressed as the average
± SEM of three independent experiments and for Z6 and Z23, the symbols include the SEM. ∗Signiﬁcantly diﬀe r e n ta tl e a s ta tP<0.01 as
determined by Student’s t-test when compared with R2Zeo cells. (b) Incorporation of 3H-thymidine in response to PDGF (25ng/mL) or
serum (2.5% FBS) stimulation was performed in indicated cell lines. Results are expressed as the fold of thymidine incorporation in presence
of PDGF or FBS over basal unstimulated condition and are the mean ± SEM of three independent experiments performed in quadruplicate.
∗Signiﬁcantly diﬀerent at least at P<0.05 as determined by Student’s t-test compared with respective basal condition. (c) Indicated serum
growing cells were submitted to DNA laddering assays according to standard procedures described in Materials and Methods. As positive
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Figure 9: Eﬀect of CKIγ2 overexpression on the CDK inhibitors p21Cip1 and p27Kip1 and the tumor suppressor p53 expression levels. (a)
From indicated cell lines, equivalent amount of total cell lysate proteins was subjected to Western Blot analysis using speciﬁc antibodies
against p21Cip1,p 2 7 Kip1, and p53. Nck Western Blot was used as loading control. (b) Similar samples were probed by western blot with
anti-HA antibodies.
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Figure 10: Downregulation of CKIγ2 in HepG2 cells decreases
expression of p27Kip1. HepG2 cells were transiently transfected
with control or hCKIγ2 (R1, R2) siRNA. Forth eight hours
after transfection, cell lysates normalized for protein content were
subjected to Western Blot analysis with indicated antibodies.
overexpression of CKIγ2 increases p27Kip1 protein levels.
However, this is also observed in ﬁbroblasts overexpressing
CKIγ3( Figure 11(a)). More importantly, transient overex-
pression of either CKIγ2o rC K I γ3 negatively impacts actin
stress ﬁbers formation (Figure 11(b)). These results suggest
that, like CKI2, CKIγ3 could also regulate the expression
of CDK inhibitors and actin cytoskeleton reorganization, at
least when overexpressed.
3.6. Inhibition of Roscovitine-Sensitive Cyclin-Dependent
K i n a s e sR e d u c e st h eL e v e lo fp 27Kip1 and Rescues Actin
Stress Fibers Formation in Fibroblasts Overexpressing CKIγ2.
Since phosphorylation of p27Kip1 at Ser10 increases its
stability and cytoplasmic accumulation [11, 12] where it can
bind and inhibit RhoA [10], we ﬁrst determined whether
p27Kip1 phosphorylation at Ser10 was increased in ﬁbroblasts
overexpressing CKIγ2. Indeed, we found that the level
of p27Kip1 phosphorylated at Ser10 was higher in CKIγ2
overexpressing than in control ﬁbroblasts (Figure 12(a)). In
addition, we found that roscovitine, a potent inhibitor of
cyclin-dependent kinases with good selectivity toward Cdk1,
Cck2, Cdk5, Cdk7, and Cdk9 [34], not only strongly reduced
the levels of p27Kip1 proteins (Figure 12(b)), but also rescued
actin stress ﬁbers formation in ﬁbroblasts overexpressing
CKIγ2( Figure 12(c)). Interestingly, we observed that Cdk5,
a roscovitine sensitive cyclin-dependent kinase that is phos-
phorylatedandactivatedbyCKI[35–37]andknowntoaﬀect
actindynamicsbyinteractingandphosphorylatingp27Kip1 at
Ser10 [13], is equally expressed in ﬁbroblasts independently
of CKIγ2 expression levels (Figure 12(a)). Collectively our
ﬁndings indicate an important role for CKIγ2i nm o d u l a t i n g
actin dynamics through a Cdks- p27Kip1 pathway, potentially
implicating Cdk5.
4. Discussion
In this study, we provide evidence that the isoform γ2
of CKI prevents the formation of actin stress ﬁbers and
delays cell cycle progression in G1. We showed that CKIγ2
induces phosphorylation and accumulation of p27Kip1 and
decreases expression levels of RhoA, which could result in
inadequate levels of activated RhoA to sustain actin stress
ﬁbers formation in ﬁbroblasts expressing higher levels of
CKIγ2. Moreover, we demonstrate that the eﬀects of CKIγ2
on p27Kip1 and actin stress ﬁbers are dependent on a subset
of Cdks. The ﬁndings that CKI regulates Cdk5 activity
[35–37] and that Cdk5 is expressed in ﬁbroblasts suggest
that the eﬀects of CKIγ2 on actin dynamics in ﬁbroblasts
overexpressing CKIγ2 potentially implicate activation of
Cdk5. Several studies indicated that Cdk5 aﬀects actin
remodeling in neuronal cells [13, 38–41]. In addition, recent
evidence point to a critical role of Cdk5 in the regulation
of p27Kip1 stability and cytoplasmic retention by directly
phosphorylating p27Kip1 on Ser10 [13]. Interestingly, a role12 International Journal of Cell Biology
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Figure 11: Overexpression of either CKIγ2o rC K I γ3 in ﬁbroblasts increases expression of p27Kip1 and inhibits formation of actin stress
ﬁbers. (a) Fibroblasts transiently transfected with plasmids encoding either HA-CKIγ2o rH A - C K I γ3 were analyzed for HA-tagged proteins
and p27Kip1 protein expression levels by Western Blot. The arrow represents HA-CKIγ2o rH A - C K I γ3, while nonspeciﬁc bands are indicated
by asterisks. Actin was used as loading control. (b) Similar ﬁbroblasts were stained for HA or actin organization using phalloidin coupled to
AlexaFluor 488. Arrows indicate HA-positive cells, while arrow heads point nontransfected cells. Pictures were taken at 63X.
for p27Kip1 in the regulation of RhoA activation [10]h a s
been reported. Indeed, p27Kip1 directly interacts with RhoA,
inhibiting RhoA activation by interfering with RhoGEFs.
Therefore, these ﬁndings are consistent with our model
suggesting that CKIγ2 regulates actin remodeling through a
Cdk5-p27Kip1-RhoA pathway (Figure 13).
The yeast homologs of the mammalian CKIγ isoforms
(Yck1/2, Cki1+/2+)[ 26]h a v eb e e ni m p l i c a t e di nv a r i o u s
biological functions. In S. cerevisiae, independent loss of
function of the YCK1 and YCK2 genes did not alter growth,
but simultaneous loss of function of both genes resulted
in lethality [42]. This established the YCK g e n e sa sa n
essential genes pair. In contrast, in S. pombe, gene disruption
experiments showed that neither cki1+ nor cki2+ is essential
for cell viability [43]. However, overexpression of cki2+,
but not cki1+, resulted in growth inhibition accompanied
by aberrant morphology. This suggests that, despite overall
similarity in structure, high homology in amino acidsInternational Journal of Cell Biology 13
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Figure 12:RoscovitinereversestheeﬀectsofCKIγ2 overexpression on p27Kip1 andactinstressﬁbers.(a)Fromindicatedcelllines,equivalent
amount of total cell lysate proteins was subjected to Western Blot analysis using speciﬁc antibodies against total and phospho-Ser10 p27Kip1,
Cdk5, and HA. β-Actin was used as loading control. (b) Equivalent amount of total cell lysate proteins from indicated cells treated or not
with roscovitine that were subjected to Western Blot analysis using speciﬁc antibodies against p27Kip1 or β-actin was used as loading control.
(c) Cells overexpressing CKIγ2 were incubated with roscovitine (25μM, 16hrs) before to be stained with phalloidin to visualized actin
organization. Images were taken at 63X.
sequence and probable overlap in substrate speciﬁcity, close
related isoforms might have non overlapping functions and
play distinct role in cells.
In this study, we showed that CKIγ2 stably overexpressed
in ﬁbroblast, alters cell morphology and formation of actin
stressﬁbersconcomitantwithlowerlevelsofactivatedRhoA,
a small GTPase that regulates actin stress ﬁbers formation
in response to growth factors [3]. Interestingly, actin stress
ﬁbers were restored by directly activating RhoA signaling
following LPA treatment or expression of a constitutively
active RhoA, suggesting that CKIγ2 regulates upstream
events leading to RhoA expression and activation. Mean-
while, we also found that CKIγ2 increases expression of the
tumor suppressor p53 and the CDK inhibitors p21Cip1 and
p27Kip1 and negatively regulates cell proliferation by delaying
cell progression through G1. To explain poor proliferation
of CKIγ2 overexpressing ﬁbroblasts, we propose that level
of RhoA activity in these cells is too low to eﬃciently
counteract the induction of the CDK inhibitors and promote
adequate timing of expression of the cyclin D1, both
processes normally under the control of RhoA [44–46].
Interestingly, Cdk5 activation in neuronal cells occurs only
in postmitotic neurons [47], suggesting that, in ﬁbroblasts
overexpressing CKIγ2, modulation of the cell cycle resulting
in decreased mitotic activity may precede and be required
for the activation of Cdk5 by CKIγ2. Although additional
experiments are required to investigate this point, here we
propose a model in which CKIγ2 induces the activation of14 International Journal of Cell Biology
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Figure 13: Model describing how CKIγ2 prevents the formation
of actin stress ﬁbers and regulates cell proliferation. Overexpression
of CKIγ2 activates Cdk5, which contributes to p27Kip1 stabiliza-
tion and cytoplasmic accumulation following phosphorylation of
p27Kip1 at Ser10. Increased cytoplasmic level of p27Kip1 correlates
with decreased cellular levels of RhoA. p27Kip1 also inhibits RhoA
activation by directly binding to RhoA and competing RhoA
interaction with RhoGEFs. Reduced RhoA signaling then results
in decreased formation of stress ﬁbers. Roscovitine rescues RhoA
activation and signaling by inhibiting CKIγ2-induced activation
of Cdk5 therefore prevents p27Kip1 phosphorylation at Ser10
and promotes p27Kip1 degradation. (1) indicates CKIγ2 kinase-
independent, while (2) represents CKIγ2 kinase-dependent.
Cdk5 in a kinase-dependent manner to promote cytoplasmic
accumulation of the CDK inhibitor p27Kip1 that prevents
RhoA activation and leads to inhibition of actin stress ﬁbers
formation (Figure 13). In summary, this study contributes to
improve our knowledge of molecular mechanisms regulating
the activity of critical proteins governing actin cytoskeleton
dynamics.
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